Given the major involvement of reactive oxygen species in the pathogenesis of AF, a recent study further confirmed the antioxidant effects of canaglifozin and its atrial anti-remodeling capacity, by demonstrating that this SGLT2 inhibitor suppressed an increase of AF inducibility [59]. This evidence concerns the gene SLC5A2 and atrial fibrillation.